A Case of Subungal Abscess And Onycholysis Related to Docetaxel.
- Author:
Min Suk LEE
1
;
Hyung Ok KIM
;
Young Min PARK
Author Information
1. Department of Dermatology, Kangnam St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Korea. yymmpark@hotmail.com
- Publication Type:Case Report
- Keywords:
Docetaxel;
Subungal abscess;
Onycholysis
- MeSH:
Abscess*;
Adult;
Breast Neoplasms;
Drug Therapy;
Female;
Head and Neck Neoplasms;
Hemorrhage;
Humans;
Lung Neoplasms;
Nails;
Onycholysis*;
Paronychia;
Pigmentation;
Skin;
Staphylococcus aureus;
Stomach Neoplasms
- From:Korean Journal of Dermatology
2003;41(10):1393-1395
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Docetaxel is a new taxoid antineoplastic drug widely used for advanced breast cancer, lung cancer, and head and neck cancer. Skin and nail change is one of the most frequent nonhematologic adverse reactions. Nail changes include dark pigmentation, subungal hemorrhage, acute paronychia, onycholysis and Beau's line. A 43-year-old woman with metastatic stomach cancer developed painful subungal abscess and secondary onycholysis of all fingernails after three courses of docetaxel chemotherapy(cumulative dose: 360mg). Puncturing under the nail plate expressed a purulent serous fluid. Microbiological cultures revealed heavy growth of Staphylococcus aureus. The docetaxel therapy was discontinused and 3rd generation cephalosporin was started. After 3-weeks antibiotic therapy, subungal abscess was improved. To our knowlege, this is the second case report of subungal abscess related to docetaxel chemotherapy.
